APA (7th ed.) Citation

Bernadou, G., Campone, M., Merlin, J., Gouilleux‐Gruart, V., Bachelot, T., Lokiec, F., . . . Ternant, D. (2016). Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non-metastatic breast cancer. British Journal of Clinical Pharmacology, 81(5), 941. https://doi.org/10.1111/bcp.12875

Chicago Style (17th ed.) Citation

Bernadou, Guillemette, et al. "Influence of Tumour Burden on Trastuzumab Pharmacokinetics in HER2 Positive Non-metastatic Breast Cancer." British Journal of Clinical Pharmacology 81, no. 5 (2016): 941. https://doi.org/10.1111/bcp.12875.

MLA (9th ed.) Citation

Bernadou, Guillemette, et al. "Influence of Tumour Burden on Trastuzumab Pharmacokinetics in HER2 Positive Non-metastatic Breast Cancer." British Journal of Clinical Pharmacology, vol. 81, no. 5, 2016, p. 941, https://doi.org/10.1111/bcp.12875.